AVANOS MEDICAL, INC. 8-K

What Happened
Avanos Medical, Inc. (AVNS) filed a Form 8-K on July 2, 2026 and issued a press release announcing that it has received all required regulatory approvals to complete the company's pending acquisition by affiliates of investment funds advised by American Industrial Partners. The press release is attached to the 8-K as Exhibit 99.1.

Key Details

• Filing date: July 2, 2026 (Form 8-K, Exhibit 99.1 press release).
• Acquirer: affiliates of investment funds advised by American Industrial Partners.
• The 8-K attaches only the press release (Exhibit 99.1) and the interactive cover page data (Exhibit 104); no additional financial statements or transaction agreements were included in this filing.
• The filing was signed by John S. Fischer, Vice President, Head of Legal and Secretary.

Why It Matters
Receiving required regulatory approvals is a major closing condition for a deal — this indicates a key hurdle has been cleared and the acquisition may move toward completion. For investors, the next material items to watch for are an 8-K reporting the closing, disclosures of transaction terms, and any filings about changes to management or listing status after the deal is completed.